The Effect of Continuous Versus Intermittent Enteral Nutrition on Metabolic Outcomes in Criticall… (NCT07173504) | Clinical Trial Compass
RecruitingNot Applicable
The Effect of Continuous Versus Intermittent Enteral Nutrition on Metabolic Outcomes in Critically Ill Patients
Netherlands124 participantsStarted 2025-09-30
Plain-language summary
The goal of this clinical trial is to investigate the effect of continuous versus intermittent enteral nutrition on metabolic outcomes in critically ill adult patients.
The aim of this study is to:
• To assess the effect of a daytime intermittent tube feeding pattern compared to standard continuous tube feeding on glycaemic control, gastrointestinal function, gastrointestinal hormones, markers of sleep quality and circadian rhythm, and lean body mass and body composition.
Participants will receive either continuous enteral nutrition for 24 hours a day or intermittent enteral nutrition during the day, consisting of 4 portions each administered over 1 hour between 8 am and 8 pm. The maximum duration of the intervention is 5 days or until participants do not receive exclusive gastric enteral nutrition.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥18 years;
✓. Receiving or eligible to receive exclusively gastric tube feeding;
✓. Expected ICU stay ≥48 hours;
✓. Receiving or anticipated to receive invasive mechanical ventilation within 48 hours after ICU admission.
Exclusion criteria
✕. The treating clinician considers participation in the study clinically contraindicated (e.g., change in feeding regimen, no possibility for placement of CGM on arms, not able to receive exclusive gastric tube feeding);
✕. Death is deemed to be imminent or inevitable during admission, and the attending doctor, patient, or substitute decision-maker is not committed to active treatment;
✕. Pregnancy;
✕. Expected fasting for ≥12 hours during the study period, for example, due to medical procedures;
✕. Readmission in last 14 days;
What they're measuring
1
Glycaemic variability
Timeframe: From enrollment to the end of the intervention at a maximum of 5 days.